V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006377 | 310003525 | null | 98 | Palliative (P) | 2014-04-26 | 2014-11-17 | Liposomal Doxorubicin (Caelyx) | N | N | 310006617 | LIPOSOMAL DOXORUBICIN |
| 310006378 | 310003525 | 1.7 | 110 | Curative (C) | 2017-09-07 | 2017-09-27 | Bevacizumab 7.5mg/kg | N | N | 310006617 | BEVACIZUMAB |
| 310006379 | 310003527 | 1.57 | 80.4 | Palliative (P) | 2017-06-25 | 2017-07-18 | Bevacizumab 7.5mg/kg | null | N | 310006620 | BEVACIZUMAB |
| 310006380 | 310007426 | 1.86 | 77.8 | Palliative (P) | 2014-01-05 | 2014-01-07 | CHOP - 21 days | N | N | 310006623 | CHOP |
| 310006381 | 310003532 | 1.5 | 59 | Curative (C) | 2015-04-01 | 2016-07-06 | GEMCARBO | 02 | N | 310006626 | GEMCARBO |
| 310006382 | 310003533 | 1.81 | 84.5 | Neo-adjuvant (N) | 2016-11-28 | 2016-12-20 | Bevacizumab 7.5mg/kg | N | N | 310006631 | BEVACIZUMAB |
| 310006383 | 310003535 | 1.68 | 71.9 | Curative (C) | 2015-08-19 | 2016-08-22 | GemCarbo Days 1+8 | 02 | N | 310006632 | GEMCARBO |
| 310006384 | 310003535 | null | null | Palliative (P) | 2015-04-21 | 2015-04-26 | CHOP - 21 days | 02 | null | 310006632 | CHOP |
| 310006385 | 310003537 | 1.58 | 57.5 | null | 2016-08-24 | 2016-09-02 | CARBOPLATIN + GEMCITABINE | 2 | N | 310006643 | GEMCARBO |
| 310006386 | 310003540 | 1.79 | 78.6 | Neo-adjuvant (N) | 2014-08-29 | 2014-08-29 | CHOP | 2 | N | 310006644 | CHOP |
| 310006387 | 310003541 | 1.78 | 88.8 | Curative (C) | 2016-12-13 | 2016-12-13 | Trial Unspecified | N | N | 310006647 | TRIAL |
| 310006388 | 310003541 | 1.6 | 62.2 | Disease modification (D) | 2015-03-29 | 2015-04-01 | CHOP | 02 | N | 310006647 | CHOP |
| 310006389 | 310003541 | 1.62 | 71.5 | Palliative (P) | 2016-02-27 | 2016-03-06 | Trial Unspecified | 01 | null | 310006647 | TRIAL |
| 310006390 | 310003543 | 1.74 | 64.3 | Palliative (P) | 2018-02-02 | 2018-08-17 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006675 | LIPOSOMAL DOXORUBICIN |
| 310006391 | 310003546 | 1.74 | 127.2 | Palliative (P) | 2014-10-20 | 2015-05-27 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310006679 | LIPOSOMAL DOXORUBICIN |
| 310006392 | 310003547 | 1.76 | 74.7 | Curative (C) | 2014-08-04 | 2015-03-18 | Bevacizumab 7.5mg/kg | 02 | N | 310006681 | BEVACIZUMAB |
| 310006393 | 310003549 | 1.73 | 89 | Neo-adjuvant (N) | 2015-12-14 | 2015-12-17 | Bevacizumab | 02 | null | 310006686 | BEVACIZUMAB |
| 310006394 | 310003551 | 1.82 | 76.4 | Adjuvant (A) | 2015-04-28 | 2015-04-28 | Trial Unspecified | 01 | N | 310006687 | TRIAL |
| 310006395 | 310007432 | 1.84 | 83 | Disease modification (D) | 2013-05-12 | 2015-03-03 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310006689 | LIPOSOMAL DOXORUBICIN |
| 310006396 | 310009464 | null | 77.8 | null | 2016-09-17 | 2016-10-29 | GemCarbo Days 1+8 | 2 | null | 310006692 | GEMCARBO |
| 310006397 | 310009464 | 1.54 | 69 | Adjuvant (A) | null | 2016-01-23 | Bevacizumab 7.5mg/kg | 2 | N | 310006692 | BEVACIZUMAB |
| 310006398 | 310007433 | 1.76 | 90 | Neo-adjuvant (N) | 2014-03-18 | 2014-04-04 | Bevacizumab 7.5mg/kg | N | N | 310006718 | BEVACIZUMAB |
| 310006399 | 310003556 | 1.57 | 104 | Adjuvant (A) | 2014-01-26 | 2014-02-03 | Liposomal Doxorubicin (Caelyx) | N | N | 310006724 | LIPOSOMAL DOXORUBICIN |
| 310006400 | 310003556 | 1.68 | 72 | Palliative (P) | null | 2015-07-21 | Bevacizumab 7.5mg/kg | N | null | 310006724 | BEVACIZUMAB |
| 310006401 | 310003557 | null | 64 | Curative (C) | 2014-04-21 | 2014-04-25 | CHOP - 21 days | N | null | 310006726 | CHOP |
| 310006402 | 310003560 | 1.79 | 68.9 | Palliative (P) | null | 2013-07-25 | Liposomal Doxorubicin (Caelyx) | 2 | N | 310006727 | LIPOSOMAL DOXORUBICIN |
| 310006403 | 310003561 | null | 93.8 | Palliative (P) | 2016-02-29 | 2016-03-03 | Liposomal Doxorubicin (Caelyx) | N | N | 310006729 | LIPOSOMAL DOXORUBICIN |
| 310006404 | 310003562 | 1.62 | 80 | Curative (C) | 2015-01-29 | 2015-01-30 | CHOP - 21 days | N | N | 310006733 | CHOP |
| 310006405 | 310007437 | null | 86.3 | Palliative (P) | 2013-03-27 | 2013-08-26 | Trial Unspecified | Y | N | 310006737 | TRIAL |
| 310006406 | 310007438 | 1.95 | 65 | Palliative (P) | 2017-05-07 | 2017-05-18 | Liposomal Doxorubicin 40mg/m2 | null | null | 310006742 | LIPOSOMAL DOXORUBICIN |
| 310006407 | 310003565 | 1.81 | 91.4 | Palliative (P) | 2014-05-14 | 2014-05-22 | CHOP | null | N | 310006744 | CHOP |
| 310006408 | 310003566 | 1.79 | 85.21 | Palliative (P) | 2014-11-12 | 2014-12-15 | Bevacizumab 7.5mg/kg | N | N | 310006747 | BEVACIZUMAB |
| 310006409 | 310003568 | 1.8 | 70 | Palliative (P) | 2017-12-05 | 2017-12-10 | Liposomal Doxorubicin 50mg/m2 | N | N | 310006749 | LIPOSOMAL DOXORUBICIN |
| 310006410 | 310003569 | 1.58 | 105.8 | null | 2013-11-22 | 2013-11-23 | Trial Unspecified | null | N | 310006750 | TRIAL |
| 310006411 | 310003569 | 1.61 | 67 | Curative (C) | 2014-11-08 | 2014-11-11 | Trial Unspecified | 02 | N | 310006750 | TRIAL |
| 310006412 | 310003571 | 1.58 | 65.7 | Palliative (P) | 2017-09-15 | 2017-09-16 | Bevacizumab | 02 | null | 310006757 | BEVACIZUMAB |
| 310006413 | 310003572 | 0 | 61.6 | Neo-adjuvant (N) | 2017-03-23 | 2017-04-05 | CHOP - 14 days | 02 | N | 310006760 | CHOP |
| 310006414 | 310003577 | 1.83 | 79.9 | Curative (C) | 2014-12-15 | 2015-02-02 | CHOP | N | N | 310006762 | CHOP |
| 310006415 | 310003577 | 1.72 | null | Curative (C) | 2016-10-03 | 2016-10-16 | CHOP - 21 days | 02 | N | 310006762 | CHOP |
| 310006416 | 310009466 | null | 101 | null | 2016-02-12 | 2016-02-12 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006763 | LIPOSOMAL DOXORUBICIN |
| 310006417 | 310003579 | 1.65 | 75.8 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-05 | GemCarbo Days 1+8 | 2 | N | 310006765 | GEMCARBO |
| 310006419 | 310007443 | null | 65 | Disease modification (D) | 2015-01-14 | 2015-01-21 | Bevacizumab | 02 | N | 310006772 | BEVACIZUMAB |
| 310006420 | 310009467 | null | 94.1 | Curative (C) | 2013-03-05 | 2013-04-15 | CHOP - 21 days | N | N | 310006772 | CHOP |
| 310006421 | 310009467 | 1.53 | 59.1 | Not known (9) | 2017-07-03 | 2017-07-28 | Bevacizumab 7.5mg/kg | 02 | null | 310006772 | BEVACIZUMAB |
| 310006422 | 310011690 | 1.89 | 134.8 | Curative (C) | 2014-01-06 | 2014-01-26 | Trial Unspecified | 01 | N | 310006783 | TRIAL |
| 310006423 | 310003583 | 1.68 | 68.9 | Disease modification (D) | 2014-08-25 | 2014-09-26 | CHOP - 21 days | N | N | 310006785 | CHOP |
| 310006424 | 310003589 | 1.56 | 58.7 | Neo-adjuvant (N) | 2017-05-21 | 2017-07-06 | Liposomal Doxorubicin (Caelyx) | N | N | 310006788 | LIPOSOMAL DOXORUBICIN |
| 310006425 | 310003590 | 1.72 | null | Curative (C) | 2016-02-06 | 2016-02-24 | Trial Unspecified | Y | N | 310006789 | TRIAL |
| 310006426 | 310003591 | 1.78 | 93.4 | Palliative (P) | 2017-05-09 | 2017-07-20 | Bevacizumab 15mg/kg | 02 | N | 310006795 | BEVACIZUMAB |
| 310006427 | 310009468 | null | 82 | Neo-adjuvant (N) | 2016-02-07 | 2016-03-10 | CHOP - 21 days | N | N | 310006818 | CHOP |